Explain the Latest Guidance for Gout Management

July 2020

You’ll get questions about managing patients with gout...due to updated guidelines.

Chronic gout. Last year, FDA warned about febuxostat increasing CV death compared to allopurinol. Now guidelines are catching up with the evidence.

Consider stopping febuxostat if a patient taking it is admitted with an MI, stroke, or other CV event.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Practice Understand COVID-19 Tests and How to Interpret Results
Antiarrhythmics Update Protocols if Your Hospital Adopts IV Sotalol Loading
New Drugs Explain How IV Meloxicam Stacks Up to Other Injectable NSAIDs
Immunology Look for Potential Med Culprits in Angioedema
Gout Explain the Latest Guidance for Gout Management
Scabies Be Prepared to Treat Scabies and Prevent Hospital Outbreaks
Practice Help Patients Navigate COVID-19 Misinformation
Antiepileptics Weigh Special Considerations for Anticonvulsant Use in Women
Kidney Disease Ensure Appropriate Oral Antibiotic Adjustments in Dialysis Patients

Explain the Latest Guidance for Gout Management

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents